However, ALT levels in splenectomized Ramp1-/- mice fell by 50% at 24 h after ConA treatment when compared with those in sham-operated Ramp1-/- mice, indicating that RAMP1 deficiency in splenocytes contributes to the aggravated ConA-mediated hepatitis. The gene discussed is RAMP1; the disease is hepatitis A virus infection.